Top Story

Ibrutinib, nivolumab combination may provide new option in non-Hodgkin lymphoma subtypes

Ibrutinib, nivolumab combination may provide new option in non-Hodgkin lymphoma subtypes
January 22, 2018

Number of opioid refills, duration of use increased risk of opioid misuse

January 22, 2018
Results published in BMJ showed the number of opioid prescription refills and duration of use among opioid naïve patients were associated with an increase in opioid…
In the Journals Plus

Universal genetic screening cost-effective for breast, ovarian cancer

January 22, 2018
Population-based screening for genetic mutations that put women at risk for breast and ovarian cancer is and may prevent more cancers than practices, according to…

National Academy of Science to honor immunotherapy pioneer

January 22, 2018
The National Academy of Sciences will present the 2018 Jessie Stevenson Kovalenko Medal to James P. Allison, MD, in recognition of outstanding research in medical…
In the Journals

Second reminder improves uptake in colon cancer screenings

January 22, 2018
Patients in the U.K. were more likely to undergo flexible sigmoidoscopy screening if they received a second follow-up reminder that included a brochure that addressed…
More Headlines »

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

This CME case study will discuss the treatment of polycythemia rubra vera.
More »
Meeting News

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
Current Issues
View the Current Issue
HemOnc Today